Fennec Pharmaceuticals Inc. (FENC)
NASDAQ: FENC · Real-Time Price · USD
6.65
+0.05 (0.76%)
Feb 21, 2025, 4:00 PM EST - Market closed
Fennec Pharmaceuticals Stock Forecast
Stock Price Forecast
The 2 analysts with 12-month price forecasts for Fennec Pharmaceuticals stock have an average target of 14, with a low estimate of 13 and a high estimate of 15. The average target predicts an increase of 110.53% from the current stock price of 6.65.
Analyst Consensus: Strong Buy
* Price targets were last updated on Dec 17, 2024.
Analyst Ratings
The average analyst rating for Fennec Pharmaceuticals stock from 2 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Sep '24 | Oct '24 | Nov '24 | Dec '24 | Jan '25 | Feb '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 2 | 2 | 2 | 2 | 2 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $13 | Strong Buy | Reiterates | $13 | +95.49% | Dec 17, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $15 → $13 | Strong Buy | Maintains | $15 → $13 | +95.49% | Aug 22, 2024 |
| Craig-Hallum | Craig-Hallum | Strong Buy Maintains $17 → $15 | Strong Buy | Maintains | $17 → $15 | +125.56% | Aug 14, 2024 |
| Craig-Hallum | Craig-Hallum | Strong Buy Maintains $20 → $17 | Strong Buy | Maintains | $20 → $17 | +155.64% | May 15, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $18 → $15 | Strong Buy | Maintains | $18 → $15 | +125.56% | May 15, 2024 |
Financial Forecast
Revenue This Year
57.47M
from 21.25M
Increased by 170.43%
Revenue Next Year
61.32M
from 57.47M
Increased by 6.70%
EPS This Year
0.23
from -0.60
EPS Next Year
0.17
from 0.23
Decreased by -24.11%
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | 94.7M | 96.9M | 126.3M | |||
| Avg | 57.5M | 61.3M | 100.1M | |||
| Low | 46.3M | 45.4M | 65.2M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | 345.7% | 68.6% | 106.0% | |||
| Avg | 170.4% | 6.7% | 63.2% | |||
| Low | 117.7% | -21.0% | 6.3% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | 1.44 | 0.51 | 2.22 | |||
| Avg | 0.23 | 0.17 | 1.46 | |||
| Low | -0.13 | -0.38 | 0.74 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | - | 125.2% | 1,177.7% | |||
| Avg | - | -24.1% | 743.1% | |||
| Low | - | - | 323.9% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.